Effect of Neuromuscular Electrical Stimulation in Patients With Chronic Low Back Pain
NCT ID: NCT04891692
Last Updated: 2024-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2021-02-22
2024-02-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-STIM Trial: Comparing the Efficacy of the Empi Select TENS to a Control for the Treatment of Chronic Lower Back Pain
NCT00709748
Stabilization Exercises Alone vs Stabilization Exercises Plus Neuromuscular Electrical Stimulation in People With Chronic Low Back Pain
NCT02864732
Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance
NCT07161648
NMES and Chronic Ankle Instability
NCT04322409
Chronic Effects of Wide-pulse Neuromuscular Electrostimulation on Neuromuscular and Functional Properties in Healthy Subjects
NCT04857710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phasic Treatment Group
Muscle therapy for the lumbar spine at the StimaWell 120MTRS system's phasic setting. Treatment at 3 kHz, modulation 50 Hz. Supervised 10 week intervention, 2 times a week. Treatment time of 20 minutes for the first 3 weeks, 25 minutes for the second 3 weeks, and 30 minutes for the final 4 weeks. 120MTRS system recalibration every fifth treatment.
StimaWell 120MTRS system
Medium-frequency electrotherapy device that delivers current via up to 12 channels. The device also provides heat therapy up to 40°C.
Combined Treatment Group
Muscle therapy for the lumbar spine at the StimaWell 120MTRS system's combined (tonic and phasic) setting. Treatment at 3 kHz, modulation 4 Hz and 50 Hz. Supervised 10 week intervention, 2 times a week. Treatment time of 20 minutes for the first 3 weeks, 25 minutes for the second 3 weeks, and 30 minutes for the final 4 weeks. 120MTRS system recalibration every fifth treatment.
StimaWell 120MTRS system
Medium-frequency electrotherapy device that delivers current via up to 12 channels. The device also provides heat therapy up to 40°C.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
StimaWell 120MTRS system
Medium-frequency electrotherapy device that delivers current via up to 12 channels. The device also provides heat therapy up to 40°C.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 to 60 years old.
* English or French speakers
* At least a 4/10 score on an 11-point Numerical Pain Rating Scale (NPRS) for pain intensity.
The score will be the average of current pain, and best and worst pain over the previous week.
* At least a 'moderate' Modified Oswestry Disability Index (ODI) score.
* Able to undergo MRI exam.
Exclusion Criteria
* Consistent motor control training for the low back and / or consistent weightlifting, power-lifting, bodybuilding, or strongman training in the previous 6 weeks
* History of lumbar surgery
* Presence of positive lumbosacral dermatomes or myotomes
* Presence of disease which could affect the stiffness of muscle tissue (collagen tissue disease, hemiplegia, multiple sclerosis, blood clots)
* Presence of systemic disease (cancer, metabolic syndrome)
* Presence of rheumatoid arthritis
* Presence of spinal stenosis, fracture, infection, or tumor
* Presence of lumbar scoliosis greater than 10 degrees
* Presence of cardiac arrhythmia
* Pregnant and breastfeeding women
* Individuals with epilepsy
* Individuals at risk for serious bleeding
* Individuals with pacemakers or metal implants
* Individuals with aneurysms or heart valve clips
* Individuals with tattoos or piercings in the lumbar spine
* Individuals who have taken prescribed muscle relaxants more than once a week over the past month
* BMI \> 30
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mitacs
INDUSTRY
Concordia University, Montreal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PEFORM Centre
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fortin M, Wolfe D, Dover G, Boily M. The effect of phasic versus combined neuromuscular electrical stimulation using the StimaWELL 120MTRS system on multifidus muscle morphology and function in patients with chronic low back pain: a randomized controlled trial protocol. BMC Musculoskelet Disord. 2022 Jul 1;23(1):627. doi: 10.1186/s12891-022-05578-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCER 20-21-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.